Vitamin A metabolism: an update.

D'Ambrosio DN, Clugston RD, Blaner WS. · 2011

Read Vitamin A metabolism: an update. by D'Ambrosio DN, Clugston RD, Blaner WS. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3042718.txt.

Introduction

D'Ambrosio, Clugston, and Blaner updated in 2011 the science of how the body handles vitamin A and its chemical relatives. These compounds, called retinoids, are needed for growth, vision, immunity, reproduction, and healthy skin. One form provides the light sensing pigment in the eye, and another switches on hundreds of genes. Humans cannot make them, so all must come from food.

The review traces how the vitamin is absorbed, carried in blood, stored, and converted between its many forms. Dozens of carrier proteins and enzymes take part, and some also handle fats and cholesterol. The authors gather the main advances of the previous ten to fifteen years. Their map helps explain both deficiency, which blinds children worldwide, and the risks of excess, and it guides work on related medicines.

Catalog record

CREATORD'Ambrosio DN, Clugston RD, Blaner WS.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE129 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3042718

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Vitamin A Metabolism: An Update By Diana N. D’Ambrosio, Robin D. Clugston, William S. Blaner Published in: Nutrients DOI: 10.3390/nu3010063 ABSTRACT Retinoids are required for maintaining many essential physiological processes in the body, including normal growth and development, normal vision, a healthy immune system, normal reproduction, and healthy skin and barrier functions. In excess of 500 genes are thought to be regulated by retinoic acid. 11-cis-retinal serves as the visual chromophore in vision. The body must acquire retinoid from the diet in order to maintain these essential physiological processes. Retinoid metabolism is complex and involves many different retinoid forms, including retinyl esters, retinol, retinal, retinoic acid and oxidized and conjugated metabolites of both retinol and retinoic acid. In addition, retinoid metabolism involves many carrier proteins and enzymes that are specific to retinoid metabolism, as well as other proteins which may be involved in mediating also triglyceride and/or cholesterol metabolism. This review will focus on recent advances for understanding retinoid metabolism that have taken place in the last ten to fifteen years. ABBREVIATIONS: ABCA1: ATP-binding cassette, sub-family A, member 1; ABCR: ATP binding cassette transporter; APO: apolipoprotein; ARAT: acyl-CoA:retinol acyltransferase; ATGL: adipose triglyceride lipase; BCMO1: β-carotene-15,15′-monooxygenase; BCMO2: β-carotene-9′,10′-monooxygenase; CEL: carboxyl ester lipase; CRABP: cellular retinoic acid-binding protein; CRBPI, -II, and -III: cellular retinol-binding protein, type I, -type II and -type III; DGAT1: diacylglycerol acyltransferase 1; GI: gastrointestinal; GLUT4: glucose transporter 4; HDL: high density lipoprotein; HPSG: heparin sulfate proteoglycans; HSC: hepatic stellate cell; HSL: hormone sensitive lipase; ISX: intestine specific homeobox; LDL: low density lipoprotein; LPL: lipoprotein lipase; LRAT: lecithin:retinol acyltransferase; LRP: LDL receptor-related protein; MEF: myocyte enhancer factor; NAFLD: non-alcoholic fatty liver disease; PLRP1: pancreatic lipase related protein 1; PLRP2: pancreatic lipase related protein 2; PPAR: peroxisome proliferator-activated receptor; PPRE: peroxisome proliferator-activated receptor response elements; PTL: pancreatic triglyceride lipase; RBP: retinol-binding protein; RDH: retinol dehydrogenase; REH: retinyl ester hydrolase; RPE: retinal pigment epithelium protein; siRNA: small inhibitory RNA; SNP: single nucleotide polymorphism; SR-B1: scavenger receptor class B, type I; STRA6: stimulated by retinoic acid 6; TTR: transthyretin; VLDL: very low density lipoprotein; WT: wild type. 1. INTRODUCTION It is nearly 100 years since the identification of vitamin A [1] in 1913 by McCollum and Davis [2], but much still remains to be learned about natural retinoid (vitamin A) metabolism and actions in the body. Many major questions regarding how retinoids are taken up from the diet and the molecular events important to retinoid storage and metabolism within specific cells and tissues need to be answered. Nevertheless, in the near 100 years that have gone by since the work of McCollum and Davis, a very extensive literature focused on retinoid metabolism and actions has accumulated. Our goal is to review important advances that have been made during the last 10 to 15 years toward understanding retinoid metabolism. This review will not concentrate on earlier work, as we will only briefly discuss what is known regarding retinoid metabolism from earlier published work to facilitate understanding of recent advances. For more information regarding seminal older research, the reader is referred to a number of extensive reviews published in the 1980s and 1990s to which this will serve as an update [3,4,5,6]. This review will focus primarily on (i) the intestinal absorption and metabolism of retinoid within the enterocyte; (ii) retinoid uptake, processing, and storage within the liver, where 70% of the retinoid stored within the body is located; and (iii) retinoid storage and metabolism in a number of extrahepatic tissues that have been the focus of recent research interest or where retinoid uptake and metabolism may be an integral component of the physiology of the tissue. The review will be primarily focused on mammals, with a few pertinent references to zebrafish, chickens and other non-mammalian species. We will not consider the molecular actions of retinoids in regulating retinoid-responsive transcription or their non-transcriptional actions. We will also not consider the metabolism of retinol to retinal or retinoic acid. Similarly, the potential roles of retinoids in either the prevention or causation of disease will be briefly discussed but not extensively covered. 2. METABOLISM WITHIN THE GASTROINTESTINAL (GI) TRACT Retinoid metabolism within the GI tract occurs predominantly within the proximal portion of the small intestine and involves metabolic events that occur both in the lumen, as well as within the enterocyte [3,4,5,6]. These events are summarized in Figure 1 and are discussed below. For optimal retinoid absorption, fat must be consumed along with the newly ingested retinoid. This fat is needed to facilitate retinoid entry into enterocytes from the lumen of the gut. In addition, a fat load is needed to allow for optimal chylomicron formation, since retinoids, like other dietary lipids, enter the body as a component of nascent triglyceride-rich chylomicrons. [Figure: General scheme for the uptake and metabolism of dietary retinoids and proretinoid carotenoids within the intestine. Dietary proretinoid carotenoids, like β-carotene, are taken up into the enterocyte through a process that involves SR-B1. Once inside the enterocyte, β-carotene can be acted upon by BCMO1 and either converted to retinal, which binds CRBPII, or can be incorporated intact and unmodified along with dietary fat and cholesterol into nascent chylomicrons. The retinal produced from β-carotene cleavage must undergo reduction to retinol. This is catalyzed by one or more not well-characterized retinal reductases. Upon conversion to retinol, the retinol formed from dietary proretinoid carotenoids is metabolically indistinguishable from retinoid arriving in the diet as preformed retinoid. Dietary retinyl ester is either hydrolyzed in the lumen of the intestine by PTL or PLRP2 or undergoes hydrolysis at the intestinal brush border catalyzed by a brush border REH. Retinol taken into the enterocyte binds to CRBPII and is esterified to retinyl ester. In response to a physiological challenge of retinol, LRAT will catalyze approximately 90% of retinyl ester formation, while the intestinal acyl‑CoA:retinol acyltransferase, DGAT1, catalyzes the remainder of retinyl ester formation. The resulting retinyl ester is then packed along with dietary fat and cholesterol into nascent chylomicrons, which are secreted into the lymphatic system.] The intestine is the primary tissue within the body where dietary proretinoid carotenoids, like β-carotene, are converted to retinoid. Dietary proretinoid carotenoids, as well as non-proretinoid carotenoids like lycopene and lutein, are incorporated into nascent chylomicrons and thus enter into the general circulation and the body. 2.1. Dietary Forms and Metabolism in the Lumen of the Intestine Retinoid arrives from the diet either as preformed retinoid, consisting predominantly of retinol and retinyl ester, or as proretinoid carotenoids, which can be converted to retinoid within the intestine and other tissues. Human serum contains β-carotene, α-carotene, cryptoxanthin, lycopene, and lutein as major components, with smaller concentrations of zeaxanthin, other xanthophylls, and polyenes such as phytofluene and phytoene, which are all acquired from the diet [7]. The key digestive processes that occur within the lumen of the intestine include the physical release of dietary retinoids and proretinoid carotenoids from the food matrix and their emulsification with dietary fatty acids and bile acids. Emulsification with free fatty acids and bile salts is required to facilitate uptake of the highly insoluble retinoids and carotenoids into enterocytes from the lumen [3,4,5,6]. Dietary retinol is taken up directly from the lumen into the enterocyte; however, dietary retinyl esters must first

Read the complete text